| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.0M | -11.9% |
| R&D Expense | $6.8M | -41.6% |
| SG&A Expense | $10.8M | -7.6% |
| Operating Income | -$22.2M | +2.1% |
| Pre-tax Income | -$21.3M | -19.0% |
| Income Tax | -$265K | -4984.4% |
| Net Income | -$18.6M | -4.2% |
| EPS (Basic) | -$4.85 | +100.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $539K | -34.5% |
| Inventory | $1.6M | +50.2% |
| Current Assets | $10.8M | -48.0% |
| Total Assets | $19.1M | -16.4% |
| Current Liabilities | $8.6M | +85.7% |
| Total Liabilities | $10.3M | +64.5% |
| Stockholders' Equity | $7.2M | -56.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.2M | +10.1% |
| Capital Expenditures | $165K | +22.5% |
| Investing Cash Flow | -$184K | -30.0% |
| Financing Cash Flow | $2.9M | -65.5% |
| Free Cash Flow | -$13.4M | +9.8% |